Londinia Opportunities Analyses - 06/14/2021 (GMT) RUBIUS THERAPEUTICS INC. - 1H
I am delighted to see that my first price objective has been achieved. I hope you've taken advantage of it.
- U.S. Stocks
- Timeframe : 1H
- - Analysis generated on
- Status : TARGET REACHED
Summary of the analysis
Trends
Short term:
Strongly bullish
Underlying:
Strongly bullish
Technical indicators
78%
11%
11%
My opinion
Bullish above 27.96 USD
My targets
28.84 USD (+1.84%)
30.19 USD (+6.59%)
My analysis
All elements being clearly bullish, it would be possible for traders to trade only long positions (at the time of purchase) on RUBIUS THERAPEUTICS INC. as long as the price remains well above 27.96 USD. The buyers' bullish objective is set at 28.84 USD. A bullish break in this resistance would boost the bullish momentum. The buyers could then target the resistance located at 30.19 USD. If there is any crossing, the next objective would be the resistance located at 32.01 USD. However, beware of bullish excesses that could lead to a possible short-term correction; but this possible correction would not be tradeable.
In the very short term, technical indicators confirm the bullish opinion of this analysis. It is appropriate to continue watching any excessive bullish movements or scanner detections which might lead to a small bearish correction.
Force
0
10
8.2
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
Additional analysis
Quotes
RUBIUS THERAPEUTICS INC. rating 28.32 USD. On the day, this instrument gained +2.61% and was between 27.01 USD and 28.51 USD. This implies that the price is at +4.85% from its lowest and at -0.67% from its highest.27.01
28.51
28.32
A bullish gap was detected at the opening by the Central Gaps scanner. There are a lot of buyers and they have the upper hand in the very short term.
Opening Gap UP
Type : Bullish
Timeframe : Openning
A study of price movements over other periods shows the following variations:
Near a new HIGH record (1 month)
Type : Bullish
Timeframe : Weekly
Technical
Technical analysis of this 1H chart of RUBIUS THERAPEUTICS INC. indicates that the overall trend is strongly bullish. 92.86% of the signals given by moving averages are bullish. This strongly bullish trend is supported by the strong bullish signals given by short-term moving averages. The Central Indicators scanner does not detect any result on moving averages that would impact this trend.
In fact, according to the parameters integrated into the Central Analyzer system, 14 technical indicators out of 18 analysed are currently bullish. But beware of excesses. The Central Indicators scanner currently detects this:
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : 1 hour
The analysis of the price chart with Central Patterns scanners does not return any result.
The Central Candlesticks scanner currently notes the presence of this pattern in Japanese candlesticks that could mark the end of the short-term trend currently underway:
Doji
Type : Neutral
Timeframe : 1 hour
ProTrendLines
S3
S2
S1
R1
R2
Price
S3 | S2 | S1 | Price | R1 | R2 | |
---|---|---|---|---|---|---|
ProTrendLines | 25.74 | 26.43 | 27.96 | 28.32 | 28.84 | 32.01 |
Change (%) | -9.11% | -6.67% | -1.27% | - | +1.84% | +13.03% |
Change | -2.58 | -1.89 | -0.36 | - | +0.52 | +3.69 |
Level | Major | Minor | Intermediate | - | Intermediate | Major |
To determine price objectives, it is also possible to use the pivot points. Here is the price position in relation to pivot points:
Daily
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 25.42 | 25.87 | 26.74 | 27.19 | 28.06 | 28.51 | 29.38 |
Camarilla | 27.24 | 27.36 | 27.48 | 27.60 | 27.72 | 27.84 | 27.96 |
Woodie | 25.62 | 25.98 | 26.94 | 27.30 | 28.26 | 28.62 | 29.58 |
Fibonacci | 25.87 | 26.38 | 26.69 | 27.19 | 27.70 | 28.01 | 28.51 |
Weekly
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 21.91 | 23.21 | 25.40 | 26.70 | 28.89 | 30.19 | 32.38 |
Camarilla | 26.64 | 26.96 | 27.28 | 27.60 | 27.92 | 28.24 | 28.56 |
Woodie | 22.37 | 23.43 | 25.86 | 26.92 | 29.35 | 30.41 | 32.84 |
Fibonacci | 23.21 | 24.54 | 25.36 | 26.70 | 28.03 | 28.85 | 30.19 |
Monthly
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 16.20 | 19.61 | 22.02 | 25.43 | 27.84 | 31.25 | 33.66 |
Camarilla | 22.83 | 23.36 | 23.90 | 24.43 | 24.96 | 25.50 | 26.03 |
Woodie | 15.70 | 19.36 | 21.52 | 25.18 | 27.34 | 31.00 | 33.16 |
Fibonacci | 19.61 | 21.83 | 23.21 | 25.43 | 27.65 | 29.03 | 31.25 |
Numerical data
The following is the status of technical indicators and moving averages registered at the time this technical analysis was created:
Technical indicators
Moving averages
RSI (14): | 63.86 | |
MACD (12,26,9): | 0.3500 | |
Directional Movement: | 15.88 | |
AROON (14): | 85.71 | |
DEMA (21): | 27.45 | |
Parabolic SAR (0,02-0,02-0,2): | 26.11 | |
Elder Ray (13): | 0.36 | |
Super Trend (3,10): | 26.23 | |
Zig ZAG (10): | 27.60 | |
VORTEX (21): | 1.0400 | |
Stochastique (14,3,5): | 94.32 | |
TEMA (21): | 27.43 | |
Williams %R (14): | -2.40 | |
Chande Momentum Oscillator (20): | 1.25 | |
Repulse (5,40,3): | 1.2700 | |
ROCnROLL: | 1 | |
TRIX (15,9): | 0.1700 | |
Courbe Coppock: | 2.75 |
MA7: | 26.11 | |
MA20: | 25.54 | |
MA50: | 24.97 | |
MA100: | 20.40 | |
MAexp7: | 27.35 | |
MAexp20: | 26.98 | |
MAexp50: | 26.33 | |
MAexp100: | 25.81 | |
Price / MA7: | +8.46% | |
Price / MA20: | +10.88% | |
Price / MA50: | +13.42% | |
Price / MA100: | +38.82% | |
Price / MAexp7: | +3.55% | |
Price / MAexp20: | +4.97% | |
Price / MAexp50: | +7.56% | |
Price / MAexp100: | +9.72% |
Quotes :
-
15 min delayed data
-
Actions NASDAQ
News
Don't forget to follow the news on RUBIUS THERAPEUTICS INC.. At the time of publication of this analysis, the latest news was as follows:
- Rubius Therapeutics to Participate in Jefferies Virtual Healthcare Conference
- Rubius Therapeutics to Present Trials in Progress Poster on the Phase 1 Clinical Trial of RTX-321 for HPV 16-Positive Cancers at the 2021 American Society of Clinical Oncology Annual Meeting
- Rubius Therapeutics Announces Publication of RTX-321 Preclinical Data in Nature Communications
- Rubius Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
- Rubius Therapeutics to Announce First Quarter 2021 Financial Results